Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.




THQ Inc. (NASDAQ:THQI) reported that its new The Penguins of Madagascar video game is now available at all major retailers across North America.

Based on the Emmy Award-winning series from Nickelodeon and DreamWorks Animation SKG, Inc. (NASDAQ:DWA), The Penguins of Madagascar video game chronicles the zany adventures of Skipper, Kowalski, Rico and Private as they use teamwork, penguin-style acrobatics and creative contraptions to solve puzzles and complete stealth-based missions.


BioScrip, Inc. (NASDAQ:BIOS) reported 2010 third quarter revenue of $441.2 million and net income of $2.0 million or $0.04 earnings per diluted share (NYSEARCA:EPS).

Adjusted EBITDA for the quarter was $18.1 million.


pwrm_logo_200x721 Power3 Medical Products, Inc. (OTC:PWRM) is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

Power3 Medical Products, Inc. previously has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc., a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy.

PWRM plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into PWRM, with PWRM remaining as the surviving company in the merger.

The acquisition of Rozetta-Cell is expected to be completed in November 2010.

Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases, for which it is currently engaged in Phase II clinical trials. The tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

For more information about this company please visit


KEYW Corporation (NASDAQ:KEYW) has reached an agreement in principle to acquire Sycamore US, a distinguished, privately held provider of cyber solutions to the U.S. Intelligence Community (IC).

The boards of directors of both companies have approved the transaction, which is expected to close in November 2010, subject to final approval by Sycamore’s stockholders and the completion and execution of definitive transaction documentation.


Alphatec Holdings, Inc. (NASDAQ:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, reported that Heather Rider, who has over 25 years of executive-level Human Resource experience in the medical device and healthcare industry, has been named ATEC’s new Senior Vice President, Global Human Resources.


The Board of Directors of Utah Medical Products, Inc. (NASDAQ:UTMD) approved a special cash dividend of ninety-six cents ($.96) per share of common stock payable on December 30, 2010 to shareholders of record at the close of business on December 15, 2010.

The one-time dividend represents about a two percent (2%) increase over the cumulative cash dividends of ninety-four cents ($.94) paid during the most recent four calendar quarters.






Sign-Up For Free Stock Alerts At


business Card 3



Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more at ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).